Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
CNS Drugs|April 13, 2021
Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort StudyNabil Seery, Sifat Sharmin, Vivien Li, et al.
JAMA Neurology|September 14, 2020
Association of Pregnancy With the Onset of Clinically Isolated SyndromeAi-Lan Nguyen, Karolina Vodehnalova, Tomas Kalincik, et al.
JAMA Neurology|September 29, 2025
Menopause Impact on Multiple Sclerosis Disability ProgressionFrancesca Bridge, Paul G Sanfilippo, Chao Zhu, et al.
Journal of Neurology|April 1, 2026
Cross-sectional brain volumetric measures and disability outcomes in relapsing-remitting multiple sclerosisMichael T G Hayes, Heidi N Beadnall, Daniel Merlo, et al.
Clinical Immunology (Orlando, Fla.)|July 4, 2024
CLADIN- CLADribine and INnate immune response in multiple sclerosis - A phase IV prospective studyMastura Monif, Richard P Sequeira, Andrea Muscat, et al.
BMJ Neurology Open|July 30, 2025
Relationship between brain atrophy and disability in a multi-site multiple sclerosis registryAi-Lan Nguyen, Dana Horakova, Eva H Havrdova, et al.
Multiple Sclerosis and Related Disorders|November 13, 2024
Utility of icobrain for brain volumetry in multiple sclerosis clinical practiceAi-Lan Nguyen, Maria Pia Sormani, Dana Horakova, et al.
Multiple Sclerosis and Related Disorders|January 10, 2019
Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort studyAi-Lan Nguyen, Eva Kubala Havrdova, Dana Horakova, et al.
The Medical Journal of Australia|February 9, 2025
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 2Jessica Shipley, James Beharry, Wei Yeh, et al.
The Medical Journal of Australia|February 9, 2025
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 1Jessica Shipley, James Beharry, Wei Yeh, et al.
Pageof 3